Clear Street downgrades Janux Therapeutics (JANX) to Hold, slashing its price target amid concerns over a lack of durability data for its lead candidate JANX007 and rising competitive pressures, despite a recent major collaboration deal with Bristol Myers Squibb.
Pakistan has announced it will not play its scheduled T20 World Cup match against India, a decision linked by officials to recent deadly attacks in Balochistan and broader geopolitical disputes involving Bangladesh's tournament exclusion.
IBM intensifies its focus on the enterprise AI market with the launch of its governed deployment platform, a strategic collaboration with e& for regulated sectors, and the appointment of PepsiCo's Ramon Laguarta to its board of directors.
The Walt Disney Company announced blockbuster quarterly earnings driven by historic box office and streaming performance, though profits were pressured by a resolved YouTube dispute, rising costs, and a broader slowdown in international travel to U.S. destinations.
BitRiver, the dominant force in Russia's Bitcoin mining sector, faces a severe financial and legal crisis as court-ordered monitoring of its parent company begins. The turmoil stems from a multi-million dollar contract dispute, regional mining bans, and mounting pressure from sanctions and tax evasion charges against its founder.
Danish brewing giant Carlsberg has agreed to sell its 50% stake in the Lhasa Brewery joint venture to its local partner, Tibet Development, for 292 million yuan ($42 million), ending a partnership marked by operational disputes and significant financial impairments.
A two-week carriage dispute between Disney and YouTube TV last November resulted in a significant financial blow to Disney's sports division, highlighting the ongoing tensions in the streaming and traditional cable landscape.
Ukrainian President Zelenskiy notes a 24-hour pause in targeted Russian strikes on energy grids, yet civilian casualties mount in frontline regions. The reported lull follows a disputed, short-term truce brokered by the U.S., as both sides prepare for talks in Abu Dhabi.
GIGABYTE is expanding its strategic partnership with AMD to launch a new generation of AI-enhanced gaming laptops, motherboards, and monitors. This collaboration integrates AMD's Ryzen AI and 3D V-Cache technologies directly into consumer hardware, aiming to deliver tangible benefits in gaming smoothness, system stability, and creative workflow acceleration.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
The Walt Disney Company posted stronger-than-expected fiscal first-quarter results, with revenue climbing to $25.98 billion. However, a costly autumn carriage dispute with YouTube TV shaved $110 million from operating income, even as the company's Experiences division and streaming services showed robust growth. All eyes are now on the board's imminent decision on CEO Bob Iger's successor.
BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.
The luxury retailer is moving to terminate its 'Saks on Amazon' partnership as part of its Chapter 11 proceedings, aiming to refocus on core luxury operations while navigating disputes over financial commitments and brand concerns.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its weight-loss drugs and enters two strategic research collaborations in gene editing and immunology, signaling aggressive growth plans amid a recent stock valuation dip.
A final arbitration ruling in favor of Venture Global LNG against Spain's Repsol resolves a high-stakes contractual dispute, providing clarity on cash flows and bolstering confidence in the company's long-term project viability amid volatile energy markets.
Tens of thousands gathered in Prague's Wenceslas Square on Sunday, voicing support for President Petr Pavel in his escalating constitutional dispute with Prime Minister Andrej Babiš's coalition government. The protest, organized by pro-democracy activists, highlights deep divisions over Ukraine policy and a controversial ministerial appointment.
BeOne Medicines (NasdaqGS: ONC) has significantly expanded its strategic partnership with systems biology firm InSysBio. The deepened collaboration aims to leverage advanced mechanistic modeling to de-risk clinical trial design, with a particular focus on optimizing dosing and preempting safety challenges like cytokine release syndrome in oncology studies.
The U.S. Air Force Research Laboratory has awarded Palladyne AI a contract for its HANGTIME project, marking a significant expansion of the company's autonomous swarm software from ground and air assets into the space domain. The deal validates the company's core technology but comes as investors weigh its growth potential against ongoing financial challenges.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Marketing technology firm Zeta Global announces a strategic collaboration with OpenAI, aiming to deeply integrate advanced AI into its platform. The move, coupled with positive buzz from CES 2026, sharpens its competitive edge in a sector dominated by giants like Salesforce and Adobe.
